NRIP1 (Nuclear Receptor Interacting Protein 1)
A key transcriptional coregulator in nuclear receptor signaling, metabolism, and cancer.
Gene Information Card
| Symbol | NRIP1 |
|---|---|
| Full Name | Nuclear Receptor Interacting Protein 1 |
| Gene Type | Protein coding |
| Chromosomal Location | 21q11.2 |
| NCBI Gene ID | 8204 ncbi.nlm.nih.gov/gene/8204 |
| Ensembl ID | ENSG00000142168 |
| UniProt ID | P48552 |
| OMIM ID | 602490 |
| HGNC ID | 8001 |
| Aliases | RIP140 |
Description
NRIP1 (nuclear receptor interacting protein 1), also known as RIP140, is a transcriptional coregulator that modulates the activity of nuclear receptors such as estrogen receptor (ER), androgen receptor (AR), and peroxisome proliferator-activated receptors (PPARs). It functions primarily as a repressor of nuclear receptor-mediated transcription by recruiting histone deacetylases and other chromatin-modifying complexes. NRIP1 plays critical roles in energy metabolism, adipogenesis, reproduction, and cancer progression. The gene is located on chromosome 21q11.2 and encodes a 1158-amino acid protein.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Breast Cancer | NRIP1 overexpression enhances ER signaling and promotes tamoxifen resistance; acts as a coactivator in certain contexts. | ClinVar, COSMIC, PMID: 19124656 |
| Endometrial Cancer | NRIP1 amplification and overexpression correlate with poor prognosis and hormone-independent growth. | COSMIC, PMID: 21804562 |
| Obesity and Metabolic Syndrome | NRIP1 knockout mice show increased energy expenditure and resistance to diet-induced obesity; human variants linked to metabolic traits. | OMIM, PMID: 16858410 |
| Prostate Cancer | NRIP1 modulates AR activity and is associated with castration-resistant prostate cancer. | COSMIC, PMID: 22926525 |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Adipose tissue | 12.5 | Medium |
| Breast | 8.3 | Low |
| Endometrium | 15.2 | Medium |
| Liver | 6.1 | Low |
| Skeletal muscle | 4.7 | Low |
| Ovary | 10.8 | Medium |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| MCF7 (breast cancer) | 18.4 | ER-positive; high NRIP1 expression |
| HepG2 (liver cancer) | 7.2 | Moderate expression |
| HeLa (cervical cancer) | 5.9 | Low expression |
| LNCaP (prostate cancer) | 14.1 | AR-positive; moderate-high expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1234C>T (p.Arg412*) | Nonsense | Rare | Loss of function; truncation of C-terminal repression domain |
| c.567_568insA (p.Glu190Argfs*12) | Frameshift | Rare | Loss of function; premature stop |
| c.2101G>A (p.Gly701Arg) | Missense | 0.01% (gnomAD) | Unknown functional effect; located in ligand-binding domain |
| c.2980C>T (p.Arg994Trp) | Missense | 0.005% | Potential gain of function; altered cofactor interaction |
Mutation functional classification
Loss of Function (LOF)
Truncating mutations (nonsense, frameshift) that remove the C-terminal repression domain or disrupt nuclear receptor binding lead to loss of repressive activity, observed in rare metabolic disorders.
Gain of Function (GOF)
Missense mutations in the ligand-binding domain (e.g., p.Arg994Trp) may enhance coactivator recruitment, contributing to hormone-independent cancer growth.
Dominant Negative (DN)
No well-characterized dominant-negative mutations reported; however, truncated isoforms could interfere with wild-type NRIP1 function.
View complete mutation data:
Gene Ontology (GO)
Pathways
• Nuclear receptor signaling (R-HSA-383280)
• PPAR signaling pathway (KEGG hsa03320)
• Estrogen signaling pathway (KEGG hsa04915)
• Adipogenesis (R-HSA-381340)
Protein Summary
NRIP1 (RIP140) is a 1158-amino acid nuclear protein that acts as a ligand-dependent coregulator for multiple nuclear receptors. It contains an N-terminal repression domain, a central nuclear receptor interaction domain with LXXLL motifs, and a C-terminal repression domain. NRIP1 recruits histone deacetylases (HDACs) and C-terminal binding protein (CtBP) to repress transcription, but can also activate transcription in certain cellular contexts. The protein is highly expressed in metabolic tissues (adipose, muscle) and hormone-responsive cancers. Post-translational modifications include phosphorylation and acetylation, which modulate its activity and stability.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| NRIP1 Knockout HEK293 Cell Line | EDJ-KQ2537 | Human | 8204 | Details Get a Quote |
| CNRIP1 Knockout HEK293 Cell Line | EDJ-KQ8311 | Human | 25927 | Details Get a Quote |
| NRIP1 Knockout A-549 Cell Line | EDJ-KQ24556 | Human | 8204 | Details Get a Quote |
| NRIP1 Knockout HCT 116 Cell Line | EDJ-KQ24557 | Human | 8204 | Details Get a Quote |
| NRIP1 Knockout HeLa Cell Line | EDJ-KQ24558 | Human | 8204 | Details Get a Quote |
| CNRIP1 Knockout HeLa Cell Line | EDJ-KQ34283 | Human | 25927 | Details Get a Quote |
| CNRIP1 Knockout A-549 Cell Line | EDJ-KQ64341 | Human | 25927 | Details Get a Quote |
| CNRIP1 Knockout HCT 116 Cell Line | EDJ-KQ72794 | Human | 25927 | Details Get a Quote |
Displaying Records 1 To 8 Of 8 Records